Luminal breast cancers are most commonly hormone-positive, overexpressing estrogen receptors (ER), and are associated with a better prognosis than HER2-enriched or basal-like breast cancers (BLBCs) [12,13,14,15]. Here, ESR1 is linked to basal-like breast carcinoma.